A systematic review on clinical adaptive radiotherapy for head and neck cancer

References

• Corry J, Peters LJ, Rischin D. Optimising the therapeutic ratio in head and neck cancer. Lancet Oncol. 2010;11(3):287–291. doi:10.1016/S1470-2045(09)70384-5.
   PubMed Web of Science ®Google Scholar
• Bollen H, van der Veen J, Laenen A, et al. Recurrence patterns after IMRT/VMAT in head and neck cancer. Front Oncol. 2021;11:720052. doi:10.3389/fonc.2021.720052.
   PubMedGoogle Scholar
• Kjems J, Gothelf AB, Håkansson K, et al. Elective nodal irradiation and patterns of failure in head and neck cancer after primary radiation therapy. Int J Radiat Oncol Biol Phys. 2016;94(4):775–782. doi:10.1016/j.ijrobp.2015.12.380.
   PubMed Web of Science ®Google Scholar
• Pagh A, Grau C, Overgaard J. Failure pattern and salvage treatment after radical treatment of head and neck cancer. Acta Oncol. 2016;55(5):625–632. doi:10.3109/0284186X.2015.1117136.
   PubMed Web of Science ®Google Scholar
• Barker JL, Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys. 2004;59(4):960–970. doi:10.1016/j.ijrobp.2003.12.024.
   PubMed Web of Science ®Google Scholar
• Hansen EK, Bucci MK, Quivey JM, et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;64(2):355–362. doi:10.1016/j.ijrobp.2005.07.957.
   PubMed Web of Science ®Google Scholar
• Yang H, Hu W, Wang W, et al. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2013;85(1):e47–e54. doi:10.1016/j.ijrobp.2012.09.033.
   PubMed Web of Science ®Google Scholar
• Bhide SA, Davies M, Burke K, et al. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J Radiat Oncol Biol Phys. 2010;76(5):1360–1368. doi:10.1016/j.ijrobp.2009.04.005.
   PubMed Web of Science ®Google Scholar
• Liu Q, Liang J, Zhou D, et al. Dosimetric evaluation of incorporating patient geometric variations into adaptive plan optimization through probabilistic treatment planning in head and neck cancers. Int J Radiat Oncol Biol Phys. 2018;101(4):985–997. doi:10.1016/j.ijrobp.2018.03.062.
   PubMed Web of Science ®Google Scholar
• Brouwer CL, Steenbakkers RJHM, Langendijk JA, et al. Identifying patients who may benefit from adaptive radiotherapy: does the literature on anatomic and dosimetric changes in head and neck organs at risk during radiotherapy provide information to help? Radiother Oncol. 2015;115(3):285–294. doi:10.1016/j.radonc.2015.05.018.
   PubMed Web of Science ®Google Scholar
• Qi XS, Santhanam A, Neylon J, et al. Near real-time assessment of anatomic and dosimetric variations for head and neck radiation therapy via graphics processing unit-based dose deformation framework. Int J Radiat Oncol Biol Phys. 2015;92(2):415–422. doi:10.1016/j.ijrobp.2015.01.033.
   PubMed Web of Science ®Google Scholar
• Lee C, Langen KM, Lu W, et al. Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. Int J Radiat Oncol Biol Phys. 2008;71(5):1563–1571. doi:10.1016/j.ijrobp.2008.04.013.
   PubMed Web of Science ®Google Scholar
• van Timmeren JE, Chamberlain M, Bogowicz M, et al. MR-guided adaptive radiotherapy for head and neck cancer: prospective evaluation of migration and anatomical changes of the major salivary glands. Cancers. 2021;13:5404. doi:10.3390/cancers13215404.
   PubMed Web of Science ®Google Scholar
• Castelli J, Simon A, Louvel G, et al. Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia. Radiat Oncol. 2015;10:6. doi:10.1186/s13014-014-0318-z.
   PubMed Web of Science ®Google Scholar
• Wang J, Bai S, Chen N, et al. The clinical feasibility and effect of online cone beam computer tomography-guided intensity-modulated radiotherapy for nasopharyngeal cancer. Radiother Oncol. 2009;90(2):221–227. doi:10.1016/j.radonc.2008.08.017.
   PubMed Web of Science ®Google Scholar
• Han C, Chen Y-J, Liu A, et al. Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70(4):1256–1262. doi:10.1016/j.ijrobp.2007.10.067.
   PubMed Web of Science ®Google Scholar
• Due AK, Vogelius IR, Aznar MC, et al. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. Radiother Oncol. 2014;111(3):360–365. doi:10.1016/j.radonc.2014.06.001.
   PubMed Web of Science ®Google Scholar
• Zukauskaite R, Hansen CR, Brink C, et al. Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods. Acta Oncol. 2017;56(11):1554–1561. doi:10.1080/0284186X.2017.1346384.
   PubMed Web of Science ®Google Scholar
• Dawson LA, Sharpe MB. Image-guided radiotherapy: rationale, benefits, and limitations. Lancet Oncol. 2006;7(10):848–858. doi:10.1016/S1470-2045(06)70904-4.
   PubMed Web of Science ®Google Scholar
• Schwartz DL. Current progress in adaptive radiation therapy for head and neck cancer. Curr Oncol Rep. 2012;14(2):139–147. doi:10.1007/s11912-012-0221-4.
   PubMed Web of Science ®Google Scholar
• van Kranen S, Hamming-Vrieze O, Wolf A, et al. Head and neck margin reduction with adaptive radiation therapy: robustness of treatment plans against anatomy changes. Int J Radiat Oncol Biol Phys. 2016;96(3):653–660. doi:10.1016/j.ijrobp.2016.07.011.
   PubMed Web of Science ®Google Scholar
• Wu Q, Chi Y, Chen PY, et al. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys. 2009;75(3):924–932. doi:10.1016/j.ijrobp.2009.04.047.
   PubMed Web of Science ®Google Scholar
• Chen AM, Daly ME, Cui J, et al. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning. Head Neck. 2014;36(11):1541–1546. doi:10.1002/hed.23477.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
   PubMed Web of Science ®Google Scholar
• Nishi T, Nishimura Y, Shibata T, et al. Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer. Radiother Oncol. 2013;106(1):85–89. doi:10.1016/j.radonc.2012.11.005.
   PubMed Web of Science ®Google Scholar
• Wang W, Yang H, Hu W, et al. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2010;77(2):617–621. doi:10.1016/j.ijrobp.2009.08.036.
   PubMed Web of Science ®Google Scholar
• Ahn PH, Chen C-C, Ahn AI, et al. Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications. Int J Radiat Oncol Biol Phys. 2011;80(3):677–685. doi:10.1016/j.ijrobp.2010.03.014.
   PubMed Web of Science ®Google Scholar
• Maheshwari G, Dhanawat A, Kumar HS, et al. Clinical and dosimetric impact of adaptive intensity-modulated radiotherapy in locally advanced head-and-neck cancer. J Cancer Res Ther. 2020;16(3):600–604. doi:10.4103/jcrt.JCRT_928_19.
   PubMed Web of Science ®Google Scholar
• McDonald BA, Vedam S, Yang J, et al. Initial feasibility and clinical implementation of daily MR-guided adaptive head and neck cancer radiation therapy on a 1.5T MR-Linac system: prospective R-IDEAL 2a/2b systematic clinical evaluation of technical innovation. Int J Radiat Oncol Biol Phys. 2021;109(5):1606–1618. doi:10.1016/j.ijrobp.2020.12.015.
   PubMed Web of Science ®Google Scholar
• Gul OV, Buyukcizmeci N, Basaran H. Dosimetric evaluation of three-phase adaptive radiation therapy in head and neck cancer. Radiat Phys Chem. 2023;202:110588. doi:10.1016/j.radphyschem.2022.110588.
   Web of Science ®Google Scholar
• Capelle L, Mackenzie M, Field C, et al. Adaptive radiotherapy using helical tomotherapy for head and neck cancer in definitive and postoperative settings: initial results. Clin Oncol (R Coll Radiol). 2012;24(3):208–215. doi:10.1016/j.clon.2011.11.005.
   PubMed Web of Science ®Google Scholar
• Schwartz DL, Garden AS, Thomas J, et al. Adaptive radiotherapy for head-and-Neck cancer: initial clinical outcomes from a prospective trial. Int J Radiat Oncol Biol Phys. 2012;83(3):986–993. doi:10.1016/j.ijrobp.2011.08.017.
   PubMed Web of Science ®Google Scholar
• Schwartz DL, Garden AS, Shah SJ, et al. Adaptive radiotherapy for head and neck cancer—dosimetric results from a prospective clinical trial. Radiother Oncol. 2013;106(1):80–84. doi:10.1016/j.radonc.2012.10.010.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhang S, Zhou L, et al. Volume and dosimetric variations during two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma. Biomed Mater Eng. 2014;24(1):1217–1225. doi:10.3233/BME-130923.
   PubMed Web of Science ®Google Scholar
• Bhandari V, Patel P, Gurjar O, et al. Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers. J Med Phys. 2014;39(3):164. doi:10.4103/0971-6203.139005.
   PubMedGoogle Scholar
• Chitapanarux I, Chomprasert K, Nobnaop W, et al. A dosimetric comparison of two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer. J Radiat Res. 2015;56(3):529–538. doi:10.1093/jrr/rru119.
   PubMed Web of Science ®Google Scholar
• Hvid CA, Elstrøm UV, Jensen K, et al. Cone-beam computed tomography (CBCT) for adaptive image guided head and neck radiation therapy. Acta Oncol. 2018;57(4):552–556. doi:10.1080/0284186X.2017.1398414.
   PubMed Web of Science ®Google Scholar
• Bahl A, Elangovan A, Dracham CB, et al. Analysis of volumetric and dosimetric changes in mid treatment CT scan in carcinoma nasopharynx: implications for adaptive radiotherapy. J Exp Ther Oncol. 2019;13:33–39.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Maulik S, Prasath S, et al. Xerostomia quality of life and resource requirements following parotid sparing adaptive radiotherapy in head and neck cancers: results of a prospective cohort study (study ID CTRI/2017/11/010683). Radiother Oncol. 2022;168:250–255. doi:10.1016/j.radonc.2022.01.020.
   PubMed Web of Science ®Google Scholar
• Peng G, Wang T, Yang KY, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012;104(3):286–293. doi:10.1016/j.radonc.2012.08.013.
   PubMed Web of Science ®Google Scholar
• O'Daniel JC, Garden AS, Schwartz DL, et al. Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? Int J Radiat Oncol Biol Phys. 2007;69(4):1290–1296. doi:10.1016/j.ijrobp.2007.07.2345.
   PubMed Web of Science ®Google Scholar
• Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127–136. doi:10.1016/S1470-2045(10)70290-4.
   PubMed Web of Science ®Google Scholar
• Castelli J, Benezery K, Hasbini A, et al. OC-0831 results of ARTIX phase III study: adaptive radiotherapy versus standard IMRT in head and neck cancer. Radiother Oncol. 2022;170: s 749–S750. doi:10.1016/S0167-8140(22)02695-0.
   Google Scholar
• Raktoe SAS, Dehnad H, Raaijmakers CPJ, et al. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2013;85(1):136–141. doi:10.1016/j.ijrobp.2012.02.042.
   PubMed Web of Science ®Google Scholar
• Bentzen J, Toustrup K, Eriksen JG, et al. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Acta Oncol. 2015;54(7):1001–1007. doi:10.3109/0284186X.2014.992547.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wan Q, Zhou Y, et al. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiother Oncol. 2011;98(1):23–27. doi:10.1016/j.radonc.2010.10.009.
   PubMed Web of Science ®Google Scholar
• Åström LM, Behrens CP, Calmels L, et al. Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: initial experience and dosimetric benefits. Radiother Oncol. 2022;171:37–42. doi:10.1016/j.radonc.2022.03.014.
   PubMed Web of Science ®Google Scholar
• Heukelom J, Fuller CD. Head and neck cancer adaptive radiation therapy (ART): conceptual considerations for the informed clinician. Semin Radiat Oncol. 2019;29(3):258–273. doi:10.1016/j.semradonc.2019.02.008.
   PubMed Web of Science ®Google Scholar